Lv1
30 积分 2025-04-01 加入
Dupilumab versus omalizumab in patients with chronic rhinosinusitis with nasal polyps and coexisting asthma (EVEREST): a multicentre, randomised, double-blind, head-to-head phase 4 trial
2天前
已完结
Targeting key proximal drivers of type 2 inflammation in disease
1个月前
已完结
Biological Treatments in Atopic Dermatitis
1个月前
已关闭
World Allergy Organization Anaphylaxis Guidelines: 2013 Update of the Evidence Base
1个月前
已完结
Efficacy and Safety of Extending Dosing Interval of Stapokibart in Patients with Atopic Dermatitis
3个月前
已完结
International validation of the Bullous Pemphigoid Disease Area Index severity score and calculation of cut-off values for defining mild, moderate and severe types of bullous pemphigoid
7个月前
已完结
Dupilumab as a novel therapy for bullous pemphigoid
7个月前
已完结
Evaluation of Dupilumab in Patients With Bullous Pemphigoid
7个月前
已完结
Steroid-induced glaucoma: Epidemiology, pathophysiology, and clinical management
7个月前
已完结
皖公网安备34019202002308
